Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Lifeline CoFRA:L8B +1.39%84 EBITDA Margin % is 31.18% as of Mar. 2026, which is 33% above its 10-year median of 23.53. GuruFocus rates FRA:L8B with a GF Score™ of 84/100 and a GF Value™ of €8.11. Among 816 Medical Devices & Instruments companies, Japan Lifeline Co ranks better than 82.48% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Japan Lifeline Co's EBITDA for the
three
months ended in Mar. 2026 was €25.1 Mil. Japan Lifeline Co's Revenue for the
three
months ended in Mar. 2026 was €80.6 Mil. Therefore, Japan Lifeline Co's EBITDA margin for the quarter that ended in Mar. 2026 was 31.18%.
Japan Lifeline Co (FRA:L8B) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Japan Lifeline Co EBITDA Margin % Related Terms
Japan Lifeline Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Japan Lifeline Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:L8B vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Japan Lifeline Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Lifeline Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Japan Lifeline Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Lifeline Co (FRA:L8B) has a EBITDA Margin % of 31.18% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Japan Lifeline Co and its competitors. This is 33% above median its historical median of 23.53. Over the past decade, Japan Lifeline Co's EBITDA Margin % has ranged from 12.18 to 27.48. According to the industry distribution chart, Japan Lifeline Co ranks #143 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 17.5%.
Is Japan Lifeline Co's EBITDA Margin % too high?
Japan Lifeline Co's current EBITDA Margin % of 31.18% is 33% above median its 10-year median of 23.53. Over the past 10 years, this metric has ranged from a low of 12.18 to a high of 27.48. The Medical Devices & Instruments industry median EBITDA Margin % is 7.46. Japan Lifeline Co's value of 31.18% is 318.2% above this industry median. Based on the distribution chart, Japan Lifeline Co ranks #143 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Japan Lifeline Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Japan Lifeline Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Lifeline Co ranks #143 out of 816 companies for EBITDA Margin %. This places Japan Lifeline Co in the top 18% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.46. Japan Lifeline Co's value of 31.18% is 318.2% above this benchmark. Historically, Japan Lifeline Co's own EBITDA Margin % has ranged from 12.18 to 27.48 over the past decade. While the company's 10-year median is 23.53 vs. the industry median of 7.46, Japan Lifeline Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.46, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Lifeline Co's current EBITDA Margin % of 31.18% is 318.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Japan Lifeline Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Lifeline Co's current EBITDA Margin % is 31.18%, which is 33% above median its own 10-year median of 23.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Lifeline Co stock overvalued right now?
Japan Lifeline Co (FRA:L8B) has a current EBITDA Margin % of 31.18%. The stock's GF Value™ is €8.11, compared to a current price of €7.30 — trading 10% below its estimated fair value. The current EBITDA Margin % is 31.18%, which is 33% above median its 10-year median of 23.53 and 318.2% above the Medical Devices & Instruments industry median of 7.46. Japan Lifeline Co's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Japan Lifeline Co (FRA:L8B), the current EBITDA Margin % is 31.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Lifeline Co (FRA:L8B) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be undervalued.
The current stock price of €7.30 is trading 10% below its estimated GF Value™ of €8.11.
Key valuation signals for FRA:L8B:
EBITDA Margin %: 31.18% (33% above median its 10-year median of 23.53)
GF Value™: €8.11 vs. price of €7.30 (10% below fair value)
Industry Position: 318.2% above the Medical Devices & Instruments median (#143 of 816)
No single metric tells the full story. See the FRA:L8B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
84GF Score
Get the complete analysis for FRA:L8B
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L8B has been successfully added to your 
